MANHARD KIMBERLY
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to MANHARD KIMBERLY. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| INBX | Purchase | 10,000 | $13.98 | $139,800 | Aug 28, 2024 | |
| HRTX | EVP, Drug Development | Option Exercise | 4,564 | — | — | Apr 13, 2023 |
| HRTX | EVP, Drug Development | Option Exercise | 4,564 | — | — | Jan 13, 2023 |
| HRTX | EVP, Drug Development | Option Exercise | 4,564 | — | — | Oct 13, 2022 |
| HRTX | EVP, Drug Development | Option Exercise | 4,564 | — | — | Jul 13, 2022 |
| HRTX | EVP, Drug Development | Other | 1,504 | $3.84 | $5,775 | May 3, 2022 |
| HRTX | EVP, Drug Development | Option Exercise | 1,250 | — | — | Apr 13, 2022 |
| HRTX | EVP, Drug Development | Option Exercise | 1,250 | — | — | Jan 13, 2022 |
| HRTX | EVP, Drug Development | Tax Withholding | 433 | $10.55 | $4,568 | Oct 13, 2021 |
| HRTX | EVP, Drug Development | Tax Withholding | 433 | $13.48 | $5,837 | Jul 13, 2021 |
| HRTX | EVP, Drug Development | Sale | 1,529 | $17.66 | $27,002 | Apr 30, 2021 |
| HRTX | EVP, Drug Development | Tax Withholding | 433 | $16.66 | $7,214 | Apr 13, 2021 |
| HRTX | EVP, Drug Development | Option Exercise | 1,250 | — | — | Jan 13, 2021 |
| HRTX | EVP, Drug Development | Sale | 10,000 | $20.00 | $200,000 | Dec 22, 2020 |
| HRTX | Executive VP, Drug Development | Other | 1,158 | $12.12 | $14,035 | May 1, 2020 |
| HRTX | Executive VP, Drug Development | Sale | 24,000 | $26.00 | $624,000 | Nov 29, 2019 |
| HRTX | Executive VP, Drug Development | Sale | 1,109 | $18.86 | $20,916 | Apr 30, 2019 |
| HRTX | Executive VP, Drug Development | Sale | 494 | $30.62 | $15,126 | Oct 31, 2018 |
| HRTX | Executive VP, Drug Development | Sale | 6,000 | $32.07 | $192,420 | Oct 1, 2018 |
| HRTX | Executive VP, Drug Development | Sale | 100 | $38.85 | $3,885 | Jul 2, 2018 |
| HRTX | Executive VP, Drug Development | Option Exercise | 18,000 | $13.00 | $234,000 | Mar 19, 2018 |
| HRTX | Executive VP, Drug Development | Option Exercise | 7,584 | $13.00 | $98,592 | Jan 10, 2018 |
| HRTX | Executive VP, Drug Development | Sale | 21,542 | $15.33 | $330,239 | Apr 24, 2017 |
| HRTX | Option Exercise | 10,500 | $8.80 | $92,400 | Jun 2, 2015 | |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 2,906 | $14.95 | $43,445 | Jun 19, 2012 |
| 0001103390 | SVP, Regulatory & Dev Ops | Disposition | 10,200 | $32.00 | $326,400 | Jun 19, 2012 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | May 29, 2012 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $31.82 | $159,100 | Apr 30, 2012 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Mar 28, 2012 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $20.99 | $104,950 | Feb 28, 2012 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Jan 30, 2012 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $16.97 | $84,850 | Dec 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $17.67 | $88,350 | Nov 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $21.27 | $106,350 | Oct 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Sep 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $15.13 | $75,650 | Aug 29, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $23.56 | $117,800 | Jul 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Jun 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | May 31, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Apr 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Mar 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $26.50 | $132,500 | Feb 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Jan 28, 2011 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Dec 28, 2010 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $22.24 | $111,200 | Nov 29, 2010 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 5,000 | $3.90 | $19,500 | Oct 28, 2010 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 5,000 | $23.03 | $115,150 | Sep 28, 2010 |
| 0001103390 | SVP, Regulatory & Dev Ops | Sale | 8,968 | $20.00 | $179,360 | Aug 30, 2010 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 2,500 | $3.90 | $9,750 | Jul 28, 2010 |
| 0001103390 | SVP, Regulatory & Dev Ops | Option Exercise | 2,500 | $3.90 | $9,750 | Jun 28, 2010 |